Alternatives to Juno Bio

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Revolutionizing genomic analysis with innovative sequencing technology.

Nevia Bio is a femtech startup focused on early detection of women's health conditions.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

AI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.

Spanish femtech startup developing AI-powered blood tests for early detection of pregnancy complications like preeclampsia from the first trimester.

Advancing at-home pet PCR diagnostics, AI health insights, and key partnerships in vet telehealth and pet service software.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Developing a microbiome-based diagnostic for early breast cancer detection.

Developing breath-based diagnostics for lung diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Cue is a health technology company developing and manufacturing a molecular diagnostic platform for rapid, lab-quality health testing at home.

Developing an automated platform for liquid biopsy sample preparation.

Leveraging the adaptive immune system to diagnose and treat disease.

Global life sciences company providing diagnostic and biopharma laboratory services.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.